Synthetic Biology in Action

John Melo, Amyris Biotechnologies

From an open-source anti-malarial compound to renewable energy resources, Amyris Biotechnologies CEO John Melo explains his enterprise’s corporate acts of altruism, as funded by the Gates Foundation. In his words, it’s a win-win situation: His organization undertakes innovative science, saves thousands of lives, and conserves natural resources.